The impact of alpha1-adrenoceptors on prostate cancer growth.
Stamatiou
Konstantinos
K
Skolarikos
Andreas
A
Sofras
Frank
F
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000453:epidemiology*; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology
D000317:Adrenergic alpha-Antagonists